Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Uzma Tanveer

Uzma Tanveer

Liaquat National Hospital
Pakistan

Title: Frequency & recurrence of nasal polyposis at tertiary care facility

Biography

Biography: Uzma Tanveer

Abstract

ABSTRACT: Introduction: Nasal polyps are grape like structures that originate in the mucous membranes lining the nasal passages or paranasal sinus. Treatment included Functional Endoscopic sinus surgery and post operative steroid therapy. The duration of steroid use is still debatable.
Objective: To assess the frequency and recurrence of patients presenting with nasal polyposis who underwent Functional Endoscopic Sinus surgery and was given topical steroids for twenty four months. Material and method: Total 90 patients diagnosed with nasal pathology were enrolled; various sign & symptoms were tabulated. Clinical and histopathological reports were analyzed. Post operative steroid dose and recurrence rate was noted . Frequency and percentage were calculated of qualitative variables, chi-square test and Fisher’s exact test was applied to see the recurrence.
Results: Total 90 patients of either gender aged between 12 to 63 years fulfilled the inclusion criteria and were enrolled in the study. The results showed that among all study patients, 53(58.9%) were male and 37(41.1%) were female. Common presenting symptoms include nasal obstruction (97%), nasal discharge (90%) and headache followed by diplopia and proptosis. From 90 cases, 73(81.2%) had Allergic sinusitis without fungus & 17(18.9%) cases had Allergic Fungal Sinusitis (Aspergillus). Postoperatively patients were given topical steroids &recurrence was seen in twelve (17.8%) patients, 9(12%) with Allergic sinusitis without fungus and 3(17%) with AFRS.
Conculsion: The incidence of AFRS is (17)18.9% of CRS which is slightly higher as reported in previous literature. Patients presented with nasal polyposis should receive steroids to prevent recurrence.